Discounts on Hepatitis C Drug Dent Gilead’s Earnings by THE ASSOCIATED PRESS

By THE ASSOCIATED PRESS

The maker of Harvoni, a treatment for hepatitis C, said sales of the drug fell 15 percent in the first quarter.

Published: April 29, 2016 at 12:00AM

from NYT Business Day http://ift.tt/1UkkxN6

from WordPress http://ift.tt/1UkkHUO
via Hadi Aboukhater